News

DelveInsight's GnRH Receptor Antagonists Market Size, Target Population, Competitive Landscape & Market Forecast report ...
Multinational Phase 2b dose selection and Phase 3 expansion study for zelpultide alfa set to begin in late Q3/Q4 2025MARIETTA, Ga., Aug. 12, 2025 /PRNewswire/ -- Airway Therapeutics, Inc., a ...
Britain's Financial Conduct Authority (FCA) said on Thursday it would roll out stricter rules for electronic payment firms ...
The World Health Organization (WHO) has officially designated Health Canada, the Ministry of Health, Labour and ...
The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a strong pipeline of clinical trials, and ...
Emma Charles shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and ...